Cencora Inc Revenue Growth Rates (COR), Current and Historic Growth - CSIMarket
CSIMarket
 


Cencora Inc   (NYSE: COR)
 

COR's Revenue Growth by Quarter and Year

Cencora Inc 's Revenue results by quarter and year




COR Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter September -
3rd Quarter June -
2nd Quarter March 78,355.92
1st Quarter December 85,932.02
FY 164,287.94





COR Revenue second quarter 2026 Y/Y Growth Comment
Cencora Inc reported Revenue growth of 3.85% year on year in the second quarter 2026, to $ 78,355.92 millions, this is lower than Cencora Inc 's recent average Revenue growth of 8.81%.
This represents worst decline in recent Company history.

Looking into second quarter 2026 results within Pharmacy Services & Retail Drugstore industry 5 other companies have achieved higher Revenue growth. While Cencora Inc ' s Revenue increase of 3.85% ranks overall at the positon no. 2385 in the second quarter 2026.




COR Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter September - 5.92 % 14.73 % -
3rd Quarter June - 8.65 % - -
2nd Quarter March 3.85 % 10.29 % - -
1st Quarter December 5.45 % 12.78 % - -
FY   - 9.31 % 326.65 % -

Financial Statements
Cencora Inc 's second quarter 2026 Revenue $ 78,355.92 millions COR's Income Statement
Cencora Inc 's second quarter 2025 Revenue $ 75,453.67 millions Quarterly COR's Income Statement


COR Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter September - 3.8 % 6.48 % -
3rd Quarter June - 6.9 % 8.52 % -
2nd Quarter March -8.82 % -7.4 % -5.31 % -
1st Quarter December 2.63 % 3.08 % 4.87 % -
FY (Year on Year)   - 9.31 % 326.65 % -




Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #6
Retail Sector #91
Overall #2385

Revenue Y/Y Growth Statistics
High Average Low
14.73 % 8.81 % 3.85 %
(Mar 31 2024)   (March 31, 2014)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #6
Retail Sector #91
Overall #2385
Revenue Y/Y Growth Statistics
High Average Low
14.73 % 8.81 % 3.85 %
(Mar 31 2024)   (March 31, 2014)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Cencora Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
8.52 % 1.47 % -8.82 %
(Jun 30 2024)  


COR's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Cencora Inc disclosed drop in Revenue from the first quarter by -8.82% to $ 78,355.92 millions, from $ 85,932.02 millions achived in the previous reporting period.

But that's not important problem, as Cencora Inc 's Revenue generally seem to plunge in this quarter.

Within Pharmacy Services & Retail Drugstore industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Cencora Inc 's Revenue growth quarter on quarter, overall rank is 1628.


Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #3
Retail Sector #56
Overall #1628
Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #3
Retail Sector #56
Overall #1628
Revenue Q/Q Growth Statistics
High Average Low
8.52 % 1.47 % -8.82 %
(Jun 30 2024)  


COR's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Cencora Inc disclosed drop in Revenue from the first quarter by -8.82% to $ 78,355.92 millions, from $ 85,932.02 millions achived in the previous reporting period.

But that's not important problem, as Cencora Inc 's Revenue generally seem to plunge in this quarter.

Within Pharmacy Services & Retail Drugstore industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Cencora Inc 's Revenue growth quarter on quarter, overall rank is 1628.


Cencora Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 328,680.02 $ 325,777.78 $ 321,332.82 $ 316,654.37 $ 310,232.19
Y / Y Revenue Growth (TTM) 5.95 % 7.45 % 9.31 % 11.57 % -
Year on Year Revenue Growth Overall Ranking # 702 # 939 # 1062 # 0 # 0
Seqeuential Revenue Change (TTM) 0.89 % 1.38 % 1.48 % 2.07 % 2.32 %
Seq. Revenue Growth (TTM) Overall Ranking # 1386 # 444 # 1811 # 2789 # 536


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2026 period, Cencora Inc 's cumulative twelve months Revenue were $ 328,680 millions, company would post below average annual Revenue growth of 2.32% year on year, if the fiscal year would end at Mar 31 2026.
A slow-down in the Cencora Inc 's Revenue growth from the 85932.02% growth in Dec 31 2025.

Among companies within the Retail sector 11 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 702, from total ranking in previous quarter at 939.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 5
Retail Sector # 12
Overall # 702

Revenue TTM Y/Y Growth Statistics
High Average Low
63925.83 %
5143.58 %
-81.13 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 51
S&P 500 # 1386
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2026 period, Cencora Inc 's cumulative twelve months Revenue were $ 328,680 millions, company would post below average annual Revenue growth of -81.13% year on year, if the fiscal year would end at Mar 31 2026.
A slow-down in the Cencora Inc 's Revenue growth from the 85932.02% growth in Dec 31 2025.

Among companies within the Retail sector 11 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 702, from total ranking in previous quarter at 939.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 5
Retail Sector # 12
Overall # 702

Revenue TTM Y/Y Growth Statistics
High Average Low
63925.83 %
5143.58 %
-81.13 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 51
S&P 500 # 1386




Other Revenue Growth
Pharmacy Services & Retail Drugstore Industry Revenue Growth Trends and Statistics
Retail Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
COR's Revenue Growth Ratio versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Mar 31 2026 within Retail SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Murphy Usa Inc 6.49%$ 6.494 millions
Brilliant Earth Group Inc 6.48%$ 6.477 millions
Performance Food Group Company6.43%$ 6.432 millions
Mister Car Wash Inc 6.21%$ 6.213 millions
Pool Corporation6.20%$ 6.205 millions
Cvs Health Corporation6.17%$ 6.172 millions
Mckesson Corporation6.02%$ 6.025 millions
Zerostack Corp 5.94%$ 5.942 millions
Playboy Inc 4.71%$ 4.713 millions
Sysco Corporation4.70%$ 4.699 millions
Hf Foods Group Inc 4.55%$ 4.553 millions
Sprouts Farmers Market Inc 4.11%$ 4.110 millions
Haverty Furniture Companies Inc3.94%$ 3.940 millions
Cencora Inc 3.85%$ 3.846 millions
Weis Markets inc3.78%$ 3.783 millions
Tractor Supply Co3.61%$ 3.608 millions
Domino s Pizza Inc 3.47%$ 3.465 millions
Penske Automotive Group Inc 3.41%$ 3.411 millions
Pc Connection Inc 3.06%$ 3.059 millions
Us Foods Holding Corp 2.77%$ 2.770 millions
A k a Brands Holding Corp 2.31%$ 2.311 millions
Sally Beauty Holdings Inc 2.26%$ 2.260 millions
Guardian Pharmacy Services Inc 2.21%$ 2.213 millions
Publix Super Markets Inc 2.02%$ 2.021 millions


About Cencora Inc Revenue Growth Rates (COR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.